feed,title,long_url,short_url
MedRxiv,Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK),https://medrxiv.org/cgi/content/short/2022.02.14.22270930v1?rss=1,https://bit.ly/3GQPNOP
MedRxiv,Fourth Dose COVID mRNA Vaccines' Immunogenicity & Efficacy Against Omicron VOC,https://medrxiv.org/cgi/content/short/2022.02.15.22270948v1?rss=1,https://bit.ly/3gQQqxm
MedRxiv,The impact of changes in mental health services in response to COVID-19 on people with mental health conditions: protocol for a rapid review,https://medrxiv.org/cgi/content/short/2022.02.15.22270931v1?rss=1,https://bit.ly/3gOWgzq
MedRxiv,"SARS-CoV-2 infection in Africa: A systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021",https://medrxiv.org/cgi/content/short/2022.02.14.22270934v1?rss=1,https://bit.ly/3H695QB
